stopped trading for 12 consecutive times, suspended trading in , resumed trading, and dropped another 44%. Is this true?
There is a stock that was suspended for a month after 12 consecutive lower limits, and fell 44.25% on the day of resumption of trading. What's happening here? The price of
stock has dropped from 20.17 yuan to 0.88 yuan. The decline lasted from December 2015 to the end of June 2022, and the decline lasted for seven years.
In this seven-year process, no matter how the performance of and is, the performance of this variety has always been a continuous decline, and its decline is relatively unique.
After the sustained decline, periodic sideways trading appeared. After the sideways trading, there were four or six consecutive lower limits. After the lower limit, it went sideways, and then there was a continuous decline after the sideways trading.
This has been done three times. Judging from recent technical analysis,
will reach a stage high of 5.65 yuan in 2022. It began to fall gradually, and 11 negative lines appeared in stages.
Especially in early February 2022, after falling below its medium and long-term trend moving average, there was an accelerated downward trend. Starting from April 15, there were twelve consecutive lower limits, and opened after a one-month trading suspension. fell by more than 40%. Investors in the
market all know that this is a product that is about to be delisted... The total share capital of
is 1.020 billion, the circulating share capital of and is 945 million, and the net assets per share have also reached 1.87 yuan. Since it is a stock that is about to be delisted, the shareholders who hold it, especially the top ten shareholders, will suffer relatively large losses. Of course, the losses of other investors will also be relatively large. In other words, the speed of wealth evaporation or wealth evaporation will be relatively large. The rate of shrinkage is unimaginable. Looking at the current top ten shareholders of
, the cumulative number of shares held by the top ten shareholders is 626 million shares, accounting for 61.12% of the total share capital. There are 33,300 A-share investor accounts, and each household holds an average of 28,300 shares in the circulating stock market. Among the top ten shareholders, four are institutional investors and six are individual investors.
has the largest number among individual investors. The number reached 16.63 million shares, and the lowest number reached 3.68 million shares.
From a fundamental point of view, this company has many concepts, including equity participation in finance, shipping, Hainan Free Trade Zone, medical beauty , equity participation in securities firm , etc. Its main business is medical treatment in the medical field. Services, medical investment, health management, etc., but no matter what the situation is, in recent years, the economic benefits of the company have never made substantial progress and have been struggling on the edge of losses. The earnings per share of
in 2013 was 0.03 yuan, the earnings per share in 2014 was -0.33 yuan, the earnings per share in 2015 was 0.04 yuan, and the earnings per share in 2016 was -0.57 yuan. The earnings per share in 2017 is -0.80 yuan, the earnings per share in 2018 is 0.13 yuan, the earnings per share in 2019 is -0.20 yuan, the earnings per share in 2020 is 0.07 yuan, and the earnings per share in 2021 is - 0.27 yuan.
In other words, it has been struggling on the verge of losing money for many years. Analyzing its operating income, the operating income of medical cosmetology is 115 million yuan, accounting for 96.96% of the main business income. The operating income of medical consulting is 2.87 million yuan, accounting for 2.43% of the main business income. The operating income of East China is 117 million yuan, accounting for 98.63% of the main business income. The operating income of the southwest region is 1.27 million, accounting for the majority. 1.07% of operating income.
means that its main business, especially medical services and medical consultation, is concentrated in East China, and the concentration rate is relatively high, reaching more than 98%. Due to the relatively high concentration of its main business and its continuous, unstable and periodic decline, it is on the verge of losing money. Since the listing of
, the funds raised through additional issuance have reached 2.56 billion yuan, and the number of dividends and dividends has been 14 times, but the dividend was 330 million yuan. The number of share capital expansions is two, and the multiple of share capital expansion is 5.15 times.
In this case, due to the continuous shrinkage of the main track or main business, this company has not made much improvement in its operations for many years, so that it is about to be delisted.
However, among the 33,300 A-share investor accounts, ordinary investors or retail investors have suffered relatively large losses. Each account holds an average of more than 28,000 shares. Among the products that are about to be delisted, the top ten shareholders hold a cumulative share of the total shares. The proportion reaching more than 60% should be said to be relatively rare.
This stock has entered the delisting consolidation period. The starting date of the consolidation period is June 28, 2022. The delisting consolidation period is 15 trading days. The last trading day is expected to be July 18, 2022.
What kind of situation is this? The actual controller of this company was once the richest man in Shanghai or Hainan, but for a relatively short period of time. With the delisting of this company, its actual controller It may also completely withdraw from the ranks of the rich.
The name of this stock is Delisted Haiyi.
What do you think? Is this the case with
?
